GALAGEN INC
10-Q, EX-27, 2000-11-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: GALAGEN INC, 10-Q, EX-10.42, 2000-11-14
Next: PATTERSON ENERGY INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM NINE MONTHS
ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                         800,191
<SECURITIES>                                         0
<RECEIVABLES>                                   96,937
<ALLOWANCES>                                    13,136
<INVENTORY>                                    132,077
<CURRENT-ASSETS>                             1,365,870
<PP&E>                                         702,287
<DEPRECIATION>                                 498,401
<TOTAL-ASSETS>                               2,017,254
<CURRENT-LIABILITIES>                          920,012
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       105,184
<OTHER-SE>                                   1,052,243
<TOTAL-LIABILITY-AND-EQUITY>                 2,017,255
<SALES>                                          9,312
<TOTAL-REVENUES>                               375,745
<CGS>                                            8,100
<TOTAL-COSTS>                                    8,100
<OTHER-EXPENSES>                             3,907,528
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (3,453,077)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (3,453,077)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (3,453,077)
<EPS-BASIC>                                      (.33)
<EPS-DILUTED>                                    (.33)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission